Resultados da pesquisa - Chen, Fangjun
- A mostrar 1 - 18 resultados de 18
-
1
-
2
-
3
-
4
Disappearance of bone metastases in chemotherapy-resistant gastric cancer treated with antigen peptide-pulsed dendritic cell-activated cytotoxic T lymphocyte immunotherapy: A case... Por Du, Juan, Wei, Jia, Yang, Yang, Su, Shu, Shao, Jie, Chen, Fangjun, Meng, Fanyan, Zou, Zhengyun, Liu, Baorui
Publicado em 2018Text -
5
-
6
Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phase Por Yang, Xufeng, Lian, Dawei, Fan, Pinglong, Xu, Yifei, Wang, Jing, Chen, Fangjun, Lai, Huanling, Jiang, Weiwen, Zhang, Linjie, Huang, Ping, Cao, Hongying
Publicado em 2019Text -
7
Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma Por Yan, Jiayao, Yu, Xiaoxiao, Chen, Xiaotong, Liu, Fangcen, Chen, Fangjun, Ding, Naiqing, Yu, Lixia, Meng, Fanyan, Shen, Jie, Wei, Jia, Liu, Baorui
Publicado em 2021Text -
8
Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report Por Liu, Chenxi, Shao, Jie, Dong, Yanbing, Xu, Qiuping, Zou, Zhengyun, Chen, Fangjun, Yan, Jing, Liu, Juan, Li, Shuangshuang, Liu, Baorui, Shen, Jie
Publicado em 2021Text -
9
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer Por Yang, Ju, Yan, Jing, Shao, Jie, Xu, Qiuping, Meng, Fanyan, Chen, Fangjun, Ding, Naiqing, Du, Shiyao, Zhou, Shujuan, Cai, Juan, Wang, Qin, Liu, Baorui
Publicado em 2019Text -
10
HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression Por Ma, Jian, Fan, Yanxin, Feng, Tingting, Chen, Fangjun, Xu, Zhipeng, Li, Suqing, Lin, Qingfeng, He, Xiaoting, Shi, Weihong, Liu, Yang, Cao, Xiufeng, Zhu, Bin, Liu, Zhihua
Publicado em 2017Text -
11
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression Por Ma, Jian, Fan, Yanxin, Feng, Tingting, Chen, Fangjun, Xu, Zhipeng, Li, Suqing, Lin, Qingfeng, He, Xiaoting, Shi, Weihong, Liu, Yang, Liu, Zhihua, Zhu, Bin, Cao, Xiufeng
Publicado em 2018Text -
12
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein Por Chen, Hong, Sha, Huizi, Zhang, Lianru, Qian, Hanqing, Chen, Fangjun, Ding, Naiqin, Ji, Liulian, Zhu, Anqing, Xu, Qiuping, Meng, Fanyan, Yu, Lixia, Zhou, Yan, Liu, Baorui
Publicado em 2018Text -
13
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression Por Ma, Jian, Fan, Yanxin, Feng, Tingting, Chen, Fangjun, Xu, Zhipeng, Li, Suqing, Lin, Qingfeng, He, Xiaoting, Shi, Weihong, Liu, Yang, Liu, Zhihua, Zhu, Bin, Cao, Xiufeng
Publicado em 2019Text -
14
Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer Por Zhu, Anqing, Sha, Huizi, Su, Shu, Chen, Fangjun, Wei, Jia, Meng, Fanyan, Yang, Yang, Du, Juan, Shao, Jie, Ji, Fuzhi, Zhou, Chong, Zou, Zhengyun, Qian, Xiaoping, Liu, Baorui
Publicado em 2018Text -
15
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer Por Ding, Naiqing, Zou, Zhengyun, Sha, Huizi, Su, Shu, Qian, Hanqing, Meng, Fanyan, Chen, Fangjun, Du, Shiyao, Zhou, Shujuan, Chen, Hong, Zhang, Lianru, Yang, Ju, Wei, Jia, Liu, Baorui
Publicado em 2019Text -
16
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer Por Su, Shu, Zou, Zhengyun, Chen, Fangjun, Ding, Naiqing, Du, Juan, Shao, Jie, Li, Lin, Fu, Yao, Hu, Bian, Yang, Yang, Sha, Huizi, Meng, Fanyan, Wei, Jia, Huang, Xingxu, Liu, Baorui
Publicado em 2016Text -
17
Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients Por Su, Shu, Hu, Bian, Shao, Jie, Shen, Bin, Du, Juan, Du, Yinan, Zhou, Jiankui, Yu, Lixia, Zhang, Lianru, Chen, Fangjun, Sha, Huizi, Cheng, Lei, Meng, Fanyan, Zou, Zhengyun, Huang, Xingxu, Liu, Baorui
Publicado em 2017Text -
18
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors Por Chen, Fangjun, Zou, Zhengyun, Du, Juan, Su, Shu, Shao, Jie, Meng, Fanyan, Yang, Ju, Xu, Qiuping, Ding, Naiqing, Yang, Yang, Liu, Qin, Wang, Qin, Sun, Zhichen, Zhou, Shujuan, Du, Shiyao, Wei, Jia, Liu, Baorui
Publicado em 2019Text